These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Cannabis derivatives and pain. A small role for delta9-tetrahydrocannabinol (THC) in some forms of multiple sclerosis. Prescrire Int; 2009 Oct; 18(103):226. PubMed ID: 19882800 [No Abstract] [Full Text] [Related]
26. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview. McCarberg BH; Barkin RL Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938 [TBL] [Abstract][Full Text] [Related]
27. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis. Khiabani HZ; Mørland J; Bramness JG Eur J Intern Med; 2008 Dec; 19(8):608-12. PubMed ID: 19046727 [TBL] [Abstract][Full Text] [Related]
28. Vaporizers for medical marijuana. Mirken B AIDS Treat News; 1999 Sep; (No 327):1, 5-7. PubMed ID: 11366582 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary function in cannabis users: Support for a clinical trial of the vaporizer. Van Dam NT; Earleywine M Int J Drug Policy; 2010 Nov; 21(6):511-3. PubMed ID: 20451365 [TBL] [Abstract][Full Text] [Related]
31. Effect of intrapulmonary tetrahydrocannabinol administration in humans. Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447 [TBL] [Abstract][Full Text] [Related]
32. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour. Korf DJ; Benschop A; Wouters M Int J Drug Policy; 2007 May; 18(3):168-76. PubMed ID: 17689363 [TBL] [Abstract][Full Text] [Related]
33. Impairment of Endothelial Function by Aerosol From Marijuana Leaf Vaporizers. Liu J; Nabavizadeh P; Rao P; Derakhshandeh R; Han DD; Guo R; Murphy MB; Cheng J; Schick SF; Springer ML J Am Heart Assoc; 2023 Dec; 12(23):e032969. PubMed ID: 38014661 [TBL] [Abstract][Full Text] [Related]
34. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine. Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349 [TBL] [Abstract][Full Text] [Related]
35. Cannabinoids inhibit the respiration of human sperm. Badawy ZS; Chohan KR; Whyte DA; Penefsky HS; Brown OM; Souid AK Fertil Steril; 2009 Jun; 91(6):2471-6. PubMed ID: 18565513 [TBL] [Abstract][Full Text] [Related]
36. [A case of cannabis-induced mania]. Bonnet U; Chang DI; Wiltfang J; Scherbaum N; Weber R Fortschr Neurol Psychiatr; 2010 Apr; 78(4):223-5. PubMed ID: 20131205 [TBL] [Abstract][Full Text] [Related]
37. Inhaled delivery of Δ(9)-tetrahydrocannabinol (THC) to rats by e-cigarette vapor technology. Nguyen JD; Aarde SM; Vandewater SA; Grant Y; Stouffer DG; Parsons LH; Cole M; Taffe MA Neuropharmacology; 2016 Oct; 109():112-120. PubMed ID: 27256501 [TBL] [Abstract][Full Text] [Related]
38. Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ Wurz GT; Montoya E; DeGregorio MW J Cannabis Res; 2022 Jul; 4(1):36. PubMed ID: 35799289 [TBL] [Abstract][Full Text] [Related]
39. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. Potter DJ; Clark P; Brown MB J Forensic Sci; 2008 Jan; 53(1):90-4. PubMed ID: 18279244 [TBL] [Abstract][Full Text] [Related]
40. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study. Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]